Literature DB >> 23087

Prolactin responses to neuroleptics in normal and schizophrenic subjects.

P H Gruen, E J Sachar, G Langer, N Altman, M Leifer, A Frantz, F S Halpern.   

Abstract

The prolactin response to neuroleptics can serve as an index of dopamine blockade in humans. Plasma prolactin increments to single doses of chlorpromazine, and prolactin decrements to single doses of levodopa, were similar in normal and schizophrenic subjects. Antischizophrenic drugs of all chemical classes stimulated prolactin release,while chemically related drugs and other psychotropic agents ineffective in schizophrenia did not. The prolactin response to neuroleptic therapy occurred in all patients, and tolerance did not develop. Within subjects, prolactin responses were graded according to neuroleptic dose, but the upper limit of sensitivity of the response curve was achieved at doses below the therapeutic range. Relative prolactin-stimulating potency in humans of chlorpromazine, thioridazine, trifluoperazine, butaperazine, and haloperidol correlated well with their relative clinical potencies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 23087     DOI: 10.1001/archpsyc.1978.01770250110011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  32 in total

Review 1.  Biomarkers for the effects of antipsychotic drugs in healthy volunteers.

Authors:  S J de Visser; J van der Post; M S Pieters; A F Cohen; J M van Gerven
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

2.  Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment.

Authors:  Jose de Leon; Francisco J Diaz; Richard C Josiassen; George M Simpson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-10       Impact factor: 5.270

3.  The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.

Authors:  Stefan Cohrs; Cornelia Röher; Wolfgang Jordan; Andreas Meier; Gerald Huether; Wolfgang Wuttke; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

Review 4.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

Review 5.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

6.  A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers.

Authors:  P de Koning; M H de Vries
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

7.  Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.

Authors:  T Kolakowska; S Fraser; M Franklin; J Knox
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.

Authors:  J I Nurnberger; S Simmons-Alling; L Kessler; S Jimerson; J Schreiber; E Hollander; C A Tamminga; N S Nadi; D S Goldstein; E S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.

Authors:  S Lal; N P Nair; J X Thavundayil; V Tawar; R Quirion; H Guyda
Journal:  J Neural Transm Gen Sect       Date:  1991

10.  Plasma levels of fluphenazine and prolactin in psychiatric patients.

Authors:  T Kitamura; D A McGovern; N W Imlah; D Wiles; A A Schiff
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.